DH - Definitive Healthcare Q2 revenue in-line with consensus

2023-08-01 09:34:03 ET

• Healthcare commercial intelligence company Definitive Healthcare ( NASDAQ: DH ) said on Tuesday that its Q2 revenue is expected to be $61M, vs. consensus of $61.10M.
• Q2 net loss is expected to be in the range of $11.4M to $11.8M, or -$0.08 per share.
• Adjusted net income is expected to be in the range of $12.3M to $12.4M, or $0.08 per diluted share. The consensus EPS estimate is $0.05.
• Adjusted EBITDA is expected to be $17.2M.
• The company said it is reaffirming its FY23 revenue of between $249.0M and $255.0M, up 12% to 15% from last year. The consensus revenue estimate is $252.30M.
• Also, the adjusted EBITDA guidance is reaffirmed at $67.0M - $71.0M.
• DH shares were trading +8.28% pre-market.
• Source: Press Release

For further details see: